Longboard Surfs PACIFIC Waves To Pivotal Phase III Epilepsy Program

Longboard announced results of its Phase Ib/IIa PACIFIC study of bexicaserin in epilepsy, quadrupling its stock price • Source: Shutterstock

More from Clinical Trials

More from R&D